New female contraceptive under development: end-user preferences revealed in web-based survey

FHS
July 26, 2023
9:01 am

Researchers investigated prospective end-user preferences for an on-demand, non-hormonal female contraception.

Fujitsu Partners with Paradigm for Enhanced Clinical Trials

What You Should Know: – Fujitsu today announced a series of initiatives aimed at attracting global clinical trials to Japan and addressing the issue of

August 26, 2024

Meta Title: “Corcept Therapeutics Inc Patent Filing for Compound of Formula I

According to GlobalData’s company profile on Corcept Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. Corcept Therapeutics‘s grant share as of

April 30, 2024

Value-Based Care Versus Fee-for-Service: Understanding the Key Differences in Healthcare Models

Ram Krishnan, CEO, Valant Value-based care and fee-for-service are two kinds of healthcare reimbursement models for pricing healthcare services. While the fee-for-service model is more

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.